Erste Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

Erste Asset Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,200	Closed	-$2.45M	–	610
2026 Q1	$2.45M	Sell	11,200 -9,100	-45%	-$2.04M	0.02%	345
2025 Q4	$4.28M	Hold	20,300	–	–	0.04%	289
2025 Q3	$3.89M	Hold	20,300	–	–	0.04%	281
2025 Q2	$3.5M	Hold	20,300	–	–	0.03%	317
2025 Q1	$3.14M	Hold	20,300	–	–	0.04%	259
2024 Q4	$2.79M	Hold	20,300	–	–	0.03%	288
2024 Q3	$2.94M	Buy	20,300 +1,800	+10%	+$243K	0.04%	279
2024 Q2	$2.5M	Hold	18,500	–	–	0.03%	287
2024 Q1	$2.75M	Hold	18,500	–	–	0.04%	277
2023 Q4	$2.36M	Hold	18,500	–	–	0.03%	277
2023 Q3	$1.76M	Hold	18,500	–	–	0.03%	286
2023 Q2	$1.62M	Hold	18,500	–	–	0.03%	305
2023 Q1	$2.01M	Hold	18,500	–	–	0.04%	286
2022 Q4	$2.24M	Buy	18,500 +7,400	+67%	+$859K	0.05%	269
2022 Q3	$1.14M	Hold	11,100	–	–	0.03%	339
2022 Q2	$1.05M	Hold	11,100	–	–	0.02%	350
2022 Q1	$1.29M	Sell	11,100 -2,900	-21%	-$336K	0.02%	336
2021 Q4	$1.87M	Hold	14,000	–	–	0.03%	298
2021 Q3	$2.2M	Hold	14,000	–	–	0.04%	266
2021 Q2	$1.88M	Hold	14,000	–	–	0.04%	289
2021 Q1	$1.8M	Hold	14,000	–	–	0.04%	282
2020 Q4	$2.33M	Buy	+14,000	New	+$2.32M	0.06%	248

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Erste Asset Management's ASND Position: Q2 2026 in Review

Erste Asset Management sold out of Ascendis Pharma A/S (ASND) in Q2 2026, closing a stake of 11,200 shares — an estimated $2.45M sold.

Erste Asset Management first reported a position in ASND in Q4 2020 and held it in 22 quarters. The position peaked at $4.28M in Q4 2025. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Erste Asset Management reported no remaining Ascendis Pharma A/S position as of Q2 2026 after selling out during the quarter.
Erste Asset Management sold 11,200 Ascendis Pharma A/S shares in Q2 2026, an estimated $2.45M.
Erste Asset Management first reported a position in Ascendis Pharma A/S in Q4 2020 and held it in 22 quarters.
Erste Asset Management's Ascendis Pharma A/S position peaked at $4.28M in Q4 2025.
311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.